Observations placeholder
Tradjenta
Identifier
020225
Type of Spiritual Experience
Background
A description of the experience
Linagliptin (BI-1356, trade names Tradjenta (US), Trajenta (worldwide)) is a DPP-4 inhibitor for treatment of type II diabetes.
On Jan, 10, 2017 3,961 people reported to have side effects when taking Tradjenta.
Among them, 7 people (0.18%) have Hallucination
Time on Tradjenta when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 15, 2016: 1,051 people reported to have side effects when taking Tradjenta. Among them, 5 people (0.48%) have Death.
Time on Tradjenta when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |